Literature DB >> 11333163

Atrial fibrillation: is rate stabilization a valid clinical strategy?

S H Hohnloser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11333163      PMCID： PMC7027678          DOI： 10.1111/j.1542-474x.2001.tb00090.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN： 1082-720X            Impact factor:   1.468


× No keyword cloud information.
  11 in total

Review 1.  Management of atrial fibrillation: therapeutic options and clinical decisions.

Authors:  E N Prystowsky
Journal:  Am J Cardiol       Date:  2000-05-25       Impact factor: 2.778

2.  Atrial arrhythmias.

Authors:  F D Murgatroyd; A J Camm
Journal:  Lancet       Date:  1993-05-22       Impact factor: 79.321

3.  Atrial fibrillation follow-up investigation of rhythm management -- the AFFIRM study design. The Planning and Steering Committees of the AFFIRM study for the NHLBI AFFIRM investigators.

Authors: 
Journal:  Am J Cardiol       Date:  1997-05-01       Impact factor: 2.778

4.  Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study.

Authors:  M Brignole; C Menozzi; L Gianfranchi; G Musso; R Mureddu; N Bottoni; G Lolli
Journal:  Circulation       Date:  1998-09-08       Impact factor: 29.690

5.  Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial.

Authors:  S H Hohnloser; K H Kuck; J Lilienthal
Journal:  Lancet       Date:  2000-11-25       Impact factor: 79.321

6.  Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation.

Authors:  S H Lee; S A Chen; C T Tai; C E Chiang; Z C Wen; J J Cheng; Y A Ding; M S Chang
Journal:  J Am Coll Cardiol       Date:  1998-03-01       Impact factor: 24.094

7.  Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens.

Authors:  R Farshi; D Kistner; J S Sarma; J A Longmate; B N Singh
Journal:  J Am Coll Cardiol       Date:  1999-02       Impact factor: 24.094

8.  Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.

Authors: 
Journal:  Arch Intern Med       Date:  1994-07-11

Review 9.  Atrial fibrillation: maintenance of sinus rhythm versus rate control.

Authors:  S M Sopher; A J Camm
Journal:  Am J Cardiol       Date:  1996-01-25       Impact factor: 2.778

10.  Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.

Authors:  E J Benjamin; D Levy; S M Vaziri; R B D'Agostino; A J Belanger; P A Wolf
Journal:  JAMA       Date:  1994-03-16       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.